Trospium: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(New page: Trospium chloride is an antispasmodic, antimuscarinic agent that is indicated for the treatment of overactive bladder. ==Effectiveness== A randomized controlled trial found that trosp...)
 
imported>Joe Quick
m (subpages)
Line 1: Line 1:
{{subpages}}
Trospium chloride is an antispasmodic, antimuscarinic agent that is indicated for the treatment of overactive bladder.
Trospium chloride is an antispasmodic, antimuscarinic agent that is indicated for the treatment of overactive bladder.


Line 9: Line 10:
==See also==
==See also==
[http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=5413 FDA approved information]
[http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=5413 FDA approved information]
[[Category:CZ Live]] [[Category:Health Sciences Workgroup]]

Revision as of 01:32, 25 November 2007

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Trospium chloride is an antispasmodic, antimuscarinic agent that is indicated for the treatment of overactive bladder.

Effectiveness

A randomized controlled trial found that trospium is effective.[1]

References

  1. Staskin D, Sand P, Zinner N, Dmochowski R (2007). "Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial". J. Urol. 178 (3 Pt 1): 978–83; discussion 983–4. DOI:10.1016/j.juro.2007.05.058. PMID 17632131. Research Blogging.

See also

FDA approved information